Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Chronic Heart Failure

Free Subscription 29.09.2025 1 Am Heart J 1 Am J Cardiol 2 Circ Heart Fail 1 Clin Cardiol 4 Eur J Heart Fail 2 Int J Cardiol 2 J Card Fail 1 J Cardiol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. WONG J, Smith J, Soh CH, Howden E, et al
   Risk-Guided Disease Management To Prevent Heart Failure In Adult Cancer Survivors of Previous Cardiotoxic Cancer Treatments: Baseline Results of the REDEEM Trial.
   Am Heart J. 2025 Sep 16:S0002-8703(25)00331-X. doi: 10.1016/j.ahj.2025.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. KIM GY, Lim SM, Lee S, Sun BJ, et al
   Outcome of Functional Mitral Regurgitation Associated with Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
   Am J Cardiol. 2025 Sep 19:S0002-9149(25)00557.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

3. AGARWAL MA, Srivastava PK, Lam CSP, Fonarow GC, et al
   National Differences in Trends for Heart Failure Hospitalizations by Sex and Race/Ethnicity.
   Circ Heart Fail. 2025 Sep 24:e013089. doi: 10.1161/CIRCHEARTFAILURE.125.013089.
   PubMed        
   
   
4. MELENOVSKY V, Jarolim P, Kutilkova E, Jenca D, et al
   Transpulmonary Proteome Gradients Identify Pathways Involved in Pulmonary Vascular Disease Due To Heart Failure.
   Circ Heart Fail. 2025 Sep 23:e013208. doi: 10.1161/CIRCHEARTFAILURE.125.013208.
   PubMed         Abstract available
   
   

   
   Clin Cardiol

5. BALATA M, Becher MU, Hassan M, Rady M, et al
   Impact of Empagliflozin Versus Dapagliflozin on Left Ventricular Remodeling in Heart Failure Patients: A 1-Year Comparative Study.
   Clin Cardiol. 2025;48:e70192.
   PubMed         Abstract available
   
   

   
   Eur J Heart Fail

6. ZHOU J, Jin X, Xu Y, Xie Z, et al
   Nationwide implementation of heart failure therapies: National Heart Failure Center Accreditation Program (HF-CAP) in China.
   Eur J Heart Fail. 2025 Sep 22. doi: 10.1002/ejhf.70035.
   PubMed         Abstract available
   
   
7. HARADA T, Reddy YNV, Sorimachi H, Obokata M, et al
   Dynamic tricuspid regurgitation in heart failure with preserved ejection fraction.
   Eur J Heart Fail. 2025 Sep 22. doi: 10.1002/ejhf.70050.
   PubMed         Abstract available
   
   
8. SIDDIQI TJ, Khan MS, Waqas SA, Van Spall HGC, et al
   Effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and cardiovascular death across varying cardiovascular-kidney-metabolic comorbidity.
   Eur J Heart Fail. 2025 Sep 22. doi: 10.1002/ejhf.70048.
   PubMed         Abstract available
   
   
9. VERSNJAK J, Kuehne T, Fahjen P, Jovanovic N, et al
   Deep phenotyping of heart failure with preserved ejection fraction through multi-omics integration.
   Eur J Heart Fail. 2025 Sep 22. doi: 10.1002/ejhf.70041.
   PubMed         Abstract available
   
   

   
   Int J Cardiol

10. VAN ESSEN BJ, Dan NAE, Tharsana GN, Kaur P, et al
    Obesity and inactivity cluster the strongest risk factor for the development of heart failure in a population-based study.
    Int J Cardiol. 2025 Sep 19:133914. doi: 10.1016/j.ijcard.2025.133914.
    PubMed         Abstract available
    
    
11. REN JM, Wang YG, Zheng JL, Wang WY, et al
    Reply to "Reconsidering thyroid hormone assessment in heart failure risk prediction".
    Int J Cardiol. 2025 Sep 16:133912. doi: 10.1016/j.ijcard.2025.133912.
    PubMed        
    
    

    
    J Card Fail

12. 
    HF STATS 2025: Heart Failure Epidemiology and Outcomes Statistics An Updated 2025 Report from the Heart Failure Society of America.
    J Card Fail. 2025 Aug 29:S1071-9164(25)00326.
    PubMed        
    
    
13. ADWETEWA-BADU A, Mukerjee T, A Sweigart B, Baleja JD, et al
    Epidermal Metabolomic Changes Following Left Ventricular Assist Device Implantation in Patients with Advanced Heart Failure.
    J Card Fail. 2025 Sep 17:S1071-9164(25)00377.
    PubMed        
    
    

    
    J Cardiol

14. SINGH YS, Matsue Y, Iso T, Fujimoto Y, et al
    Daprodustat for patients with heart failure and renal Anemia: A pilot multicenter, open-label, randomized controlled study.
    J Cardiol. 2025 Sep 18:S0914-5087(25)00241-2. doi: 10.1016/j.jjcc.2025.
    PubMed         Abstract available
    
    

    
    PLoS One

15. AOKI T, Suzuki S, Minamisawa M, Yoshie K, et al
    A novel risk score model for predicting mortality in heart failure with preserved ejection fraction: Insights from the CURE-HF Registry-ApHAC score.
    PLoS One. 2025;20:e0332913.
    PubMed         Abstract available
    
    
16. YANG Y, Ou Y, Mo G, Wen J, et al
    Inhibition of LncRNA Kcnq1ot1 suppresses hypoxia-induced pyroptosis of H9C2 cells by regulating miR-27b-3p.
    PLoS One. 2025;20:e0332892.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.